Treatment Options For Acne Patients Post Accutane’s Withdrawal From US Market

Roche Holding AG, the world’s biggest maker of cancer drugs, recently announced the withdrawal of its Accutane acne medicine from the US Market. (Source: Pharmaceutical Online News)

Read the original here:
Treatment Options For Acne Patients Post Accutane’s Withdrawal From US Market

Related posts:

1. Ranbaxy recalls drugs for skin disease from US market Pharma major Ranbaxy Laboratories today said its US-based subsidiary, Ranbaxy...
2. Home-use acne devices offer expanded options for patients Acne affects up to 90 percent of teenagers at some...
3. Sanofi to enter lucrative acne market France-based pharmaceutical major Sanofi has acquired the rights to an...
4. First-cycle rash in patients receiving cetuximab-based treatment for NSCLC associated with improved outcome? Source: Lancet Oncology Area: News According to a subgroup analysis...
5. Acne Patients Happy With Online Follow-Up Care Outcomes similar for in-office visit or 'e-visit' using images sent...

Leave a comment

Name (required)

E-mail (required)

URI

Your Message